| Entry |
|
|---|
| Name |
Rufloxacin (INN) |
|---|
| Formula |
C17H18FN3O3S
|
|---|
| Exact mass |
363.1053
|
|---|
| Mol weight |
363.4065
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antibacterial, Nucleic acid biosynthesis inhibitor |
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA10 Rufloxacin
D02474 Rufloxacin (INN)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG00622 Rufloxacin
D02474 Rufloxacin
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D02474 Rufloxacin (INN)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG00622 Rufloxacin
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 25
1 C8y C 23.3821 -16.4047
2 C8y C 22.1687 -17.1047
3 C8y C 23.3821 -15.0045
4 N4y N 24.5955 -17.1047
5 C8y C 20.9552 -16.3581
6 S2x S 22.1687 -18.5049
7 C8y C 24.5955 -14.3045
8 C8x C 22.1687 -14.2112
9 C8x C 25.8556 -16.4514
10 C1x C 24.5955 -18.5516
11 N1y N 19.8351 -17.1047
12 C8y C 20.9552 -14.9112
13 C1x C 23.3821 -19.2049
14 C8y C 25.8556 -15.0045
15 O5x O 24.5955 -12.9043
16 C1x C 19.8351 -18.5516
17 C1x C 18.5749 -16.5447
18 X F 19.7885 -14.2112
19 C6a C 26.9757 -14.4445
20 C1x C 18.6684 -19.2983
21 C1x C 17.3615 -17.2447
22 O6a O 26.9757 -13.0443
23 O6a O 28.0958 -15.0979
24 N1y N 17.3615 -18.6916
25 C1a C 16.1947 -19.4383
BOND 28
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 1
9 4 10 1
10 5 11 1
11 5 12 1
12 6 13 1
13 7 14 1
14 7 15 2
15 11 16 1
16 11 17 1
17 12 18 1
18 14 19 1
19 16 20 1
20 17 21 1
21 19 22 2
22 19 23 1
23 20 24 1
24 24 25 1
25 8 12 2
26 9 14 2
27 10 13 1
28 21 24 1
|
|---|
